Literature DB >> 3257577

Learning from lesions: patterns of tissue inflammation in leprosy.

R L Modlin1, J Melancon-Kaplan, S M Young, C Pirmez, H Kino, J Convit, T H Rea, B R Bloom.   

Abstract

The clinical forms of leprosy constitute a spectrum that correlates closely with the degree of cell-mediated immunity. Patients with tuberculoid leprosy develop strong cell-mediated responses and have only a few, localized lesions, whereas patients with multibacillary lepromatous leprosy are specifically unresponsive to antigens of Myobacterium leprae. T cells of the CD4+ subset predominate in tuberculoid lesions, whereas CD8+ cells predominate in lepromatous lesions. Monoclonal antibodies that distinguish subpopulations of CD4+ and CD8+ cells were used to analyze the distribution of T cells infiltrating lesions across the disease spectrum. In lepromatous lesions, T cells of T-suppressor phenotype (9.3-) were the predominant CD8+ cells and suppressor/inducer cells (2H4+, Leu-8+) represented half of the CD4+ subset. In tuberculoid lesions, helper T cells (CD4+4B4+) outnumbered suppressor/inducer T cells by 14:1, compared with a ratio of 1.2:1 in peripheral blood. Analysis of the precursor frequency of antigen-reactive T cells permitted us to estimate that there was a 100-fold enrichment of T cells able to proliferate in response to M. leprae antigens in tuberculoid lesions (2/100), when compared with blood from the same patients. The methods used here to characterize the T-lymphocyte subsets and frequency of antigen-reactive T cells in leprosy may be useful in analyzing immunological reactions occurring in lesions of other inflammatory and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257577      PMCID: PMC279737          DOI: 10.1073/pnas.85.4.1213

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  The isolation and characterization of the human helper inducer T cell subset.

Authors:  C Morimoto; N L Letvin; A W Boyd; M Hagan; H M Brown; M M Kornacki; S F Schlossman
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

2.  Monoclonal antibody 9.3 and anti-CD11 antibodies define reciprocal subsets of lymphocytes.

Authors:  H Yamada; P J Martin; M A Bean; M P Braun; P G Beatty; K Sadamoto; J A Hansen
Journal:  Eur J Immunol       Date:  1985-12       Impact factor: 5.532

3.  T lymphocyte subsets in the skin lesions of patients with leprosy.

Authors:  R L Modlin; F M Hofman; C R Taylor; T H Rea
Journal:  J Am Acad Dermatol       Date:  1983-02       Impact factor: 11.527

4.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

5.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

6.  In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor.

Authors:  R L Modlin; F M Hofman; D A Horwitz; L A Husmann; S Gillis; C R Taylor; T H Rea
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

7.  Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+CD45R-p80+ subpopulation.

Authors:  N K Damle; A L Childs; L V Doyle
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

8.  Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.

Authors:  J Convit; N Aranzazu; M Ulrich; M E Pinardi; O Reyes; J Alvarado
Journal:  Int J Lepr Other Mycobact Dis       Date:  1982-12

9.  The isolation and characterization of the human suppressor inducer T cell subset.

Authors:  C Morimoto; N L Letvin; J A Distaso; W R Aldrich; S F Schlossman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes.

Authors:  W C Van Voorhis; G Kaplan; E N Sarno; M A Horwitz; R M Steinman; W R Levis; N Nogueira; L S Hair; C R Gattass; B A Arrick; Z A Cohn
Journal:  N Engl J Med       Date:  1982-12-23       Impact factor: 91.245

View more
  47 in total

1.  Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.

Authors:  Stanley M Spinola; Cliffton T H Bong; Andrew L Faber; Kate R Fortney; Stacy L Bennett; Carisa A Townsend; Beth E Zwickl; Steven D Billings; Tricia L Humphreys; Margaret E Bauer; Barry P Katz
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

Review 2.  T cell and cytokine patterns in leprosy skin lesions.

Authors:  P A Sieling; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1992

3.  IL-1β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells.

Authors:  David I Weiss; Feiyang Ma; Alexander A Merleev; Emanual Maverakis; Michel Gilliet; Samuel J Balin; Bryan D Bryson; Maria Teresa Ochoa; Matteo Pellegrini; Barry R Bloom; Robert L Modlin
Journal:  J Immunol       Date:  2019-06-24       Impact factor: 5.422

4.  Immunoregulation in onchocerciasis. Functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy.

Authors:  D O Freedman; A Lujan-Trangay; C Steel; C Gonzalez-Peralta; T B Nutman
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

5.  Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation.

Authors:  Peter A Sieling; Preston J Hill; Karen M Dobos; Kerry Brookman; Andrew M Kuhlman; Mario Fabri; Stephan R Krutzik; Thomas H Rea; Darragh G Heaslip; John T Belisle; Robert L Modlin
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

6.  Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy.

Authors:  A H Zea; M T Ochoa; P Ghosh; D L Longo; W G Alvord; L Valderrama; R Falabella; L K Harvey; N Saravia; L H Moreno; A C Ochoa
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.

Authors:  Rosane M B Teles; Rose B Teles; Thais P Amadeu; Danielle F Moura; Leila Mendonça-Lima; Helen Ferreira; Italo M C F Santos; José A C Nery; Euzenir N Sarno; Elizabeth P Sampaio
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

8.  Fibronectin-binding antigen 85 and the 10-kilodalton GroES-related heat shock protein are the predominant TH-1 response inducers in leprosy contacts.

Authors:  P Launois; M N N'Diaye; J L Cartel; I Mane; A Drowart; J P Van Vooren; J L Sarthou; K Huygen
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues.

Authors:  A Rambukkana; J D Burggraaf; W R Faber; M Harboe; P Teeling; S Krieg; P K Das
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  High-resolution sonography: a new technique to detect nerve damage in leprosy.

Authors:  Suman Jain; Leo H Visser; T L N Praveen; P Narasimha Rao; Thummalakunta Surekha; Ramesh Ellanti; Thummalakunta L N Abhishek; Indira Nath
Journal:  PLoS Negl Trop Dis       Date:  2009-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.